🇺🇸 ZALTOPROFEN in United States

74 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 20 April 2025 – 20 April 2026
• Total reports: 74

Most-reported reactions

1. Pyrexia — 12 reports (16.22%)
2. Agranulocytosis — 9 reports (12.16%)
3. Condition Aggravated — 9 reports (12.16%)
4. Pneumonia — 9 reports (12.16%)
5. Arthralgia — 7 reports (9.46%)
6. Alanine Aminotransferase Increased — 6 reports (8.11%)
7. Aspartate Aminotransferase Increased — 6 reports (8.11%)
8. Pain — 6 reports (8.11%)
9. Decreased Appetite — 5 reports (6.76%)
10. Depressed Level Of Consciousness — 5 reports (6.76%)

Source database →

Frequently asked questions

Is ZALTOPROFEN approved in United States?

ZALTOPROFEN does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for ZALTOPROFEN in United States?

Marketing authorisation holder not available in our data.